Event Information

Time：July 15, 2014 (Tuesday) 15:00-17:00

Place：TRPMA Conference Room
（1F, No. 465-1, Sec. 6, Zhongxiao E. Rd., Nangang Dist., Taipei City 11557, Taiwan）

The TRPMA invited Dr Wu Duu-Gong to give a talk on the “development of Nano-based drugs and the review and approval process”. Dr Wu is the Director of Regulatory Consulting of PPD, a leading global clinical research organization. This event forms part of the advanced RA personnel training program commissioned by the TFDA to the TRPMA and attracted an audience of the officials of the TFDA and the CDE and industry practitioners. Ms Dai Shue-yong, on behalf of the organizers, presented the certificate of appreciation to Dr Wu.

Dr Wu Duu-Gong was giving a talk on the “development of Nano-based drugs and the review and approval process”.

Ms Dai Shue-yong, on behalf of the organizers, was presenting the certificate of appreciation to Dr Wu.